Researchers at CDER focus on developing the scientific knowledge, methods, tools, and standards needed to develop and evaluate new drugs. In this effort, CDER also engages the wider research community in collaborative research to address critical gaps in CDER’s scientific knowledge that hinder drug development. At public meetings, CDER staff obtain vital information from patients to identify and address unmet medical needs. The new knowledge and capabilities obtained through these efforts, and the opportunities they provide to further drug development, are communicated to sponsors and the wider scientific community through scientific guidances, peer-reviewed publications, and a variety of formal and informal meetings, including scientific workshops and advisory committees.
- The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. The data presented in the visualizations above can be accessed by clicking on the link labeled "Download Policy and Science Development Dataset" located right below the visualizations.
- Scientific Publications by FDA Staff is intended for retrieving detailed information for individual publications.
- As of 2018, these numbers do not include 'epubs ahead of print' publications to prevent double counting if and when the print version is added to the FDA's publications database.